Market Snapshot: Three Acute Migraine Launches Are First In Over 20 Years

Lilly, Allergan and Biohaven plan to launch oral drugs for on-demand treatment of migraine attacks in the first quarter, hoping to harness a large market where new preventive therapies are already competing for patients.

pain killer stop headache migraine, no more suffering painkiller paracetamol aspirine merphine medicine treatment prevention and therapy
Acute treatments are used to stop migraines when they occur • Source: Shutterstock

More from Market Snapshot

More from Scrip